FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Teva Pharmaceuticals Carton label: Testosterone Gel 1% Recall

Carton label: Testosterone Gel 1%, 2

Teva Pharmaceuticals USA, Inc · Parsippany, NJ

Risk level
Class III
Reported by FDA
Dec 10, 2025
Recall ID
D-0198-2026
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Carton label: Testosterone Gel 1% starting Nov 7, 2025. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0198-2026 on Dec 10, 2025. Reason: Defective Container - A defect in the side-seal which allows leakage of product. Status: Ongoing.

Why it was recalled

Defective Container - A defect in the side-seal which allows leakage of product.

Product description

Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17.

Lot numbers, UPCs & expiration codes

Lot #100068692, Exp.: 04/30/2027

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0198-2026
Classification
Class III
Status
Ongoing
Recall initiated
Nov 7, 2025
FDA report date
Dec 10, 2025
Quantity
15,944 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA, Inc

Original FDA data

Every field from FDA enforcement report D-0198-2026, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Ongoing
Country
United States
Event ID
97944
Address
400 Interpace Pkwy Bldg A
Code information
Lot #100068692, Exp.: 04/30/2027
Postal code
07054-1120
Report date
Dec 10, 2025
Product type
Drugs
Recall number
D-0198-2026
Classification
Class III
Recalling firm
Teva Pharmaceuticals USA, Inc
Product quantity
15,944 cartons
Reason for recall
Defective Container - A defect in the side-seal which allows leakage of product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17.
Distribution pattern
U.S. Nationwide
Recall initiation date
Nov 7, 2025
Initial firm notification
Letter
Center classification date
Dec 1, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0198-2026, published Dec 10, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls